Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine for Improvement of Uterine Artery Pulsatility Index in Pregnant Women
IRCT20180416039335N1Phase 4Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of arginine in abnormal uterine artery blood flow, sponsored by Arak University of Medical Sciences. Primary endpoint: Change in uterine artery pulsatility index. Started Apr 2024; status: completed.
02
Drugs
arginine
03
Conditions
abnormal uterine artery blood flow
Beyond the preview
Go deeper on IRCT20180416039335N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039335N1.